PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding PolyPid Ltd. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 9 | 12 | +3 |
| Shares | 1.21M | 1.92M | +715.3K (+59.3%) |
| Value | $5.18M | $6.64M | +$1.46M (+28.2%) |
New holders (3)
Institutions that held PolyPid Ltd. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 138,504 | $476.5K | 0.30% |
| TD Waterhouse Canada Inc. | 781 | $2.77K | 0.00% |
| Golden State Equity Partners | 90 | $309 | 0.00% |
Sold out (0)
Institutions that held PolyPid Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.
None.